Catyalyst Pharmaceutical Partners (CPRX) Posts Q4 Loss of 10c/Share

April 2, 2012 8:04 AM

Catyalyst Pharmaceutical Partners (NASDAQ: CPRX) reported Q4 EPS of ($0.10), $0.04 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Catyalyst Pharmaceutical Partners (CPRX) click here.

No results found